发布求助
文献互助 智能选刊 最新文献

Annals of Oncology最新文献

筛选
英文 中文
42P Real-world outcomes of anti-EGFR rechallenge in RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC) 抗egfr再挑战在RAS/BRAF野生型（wt）转移性结直肠癌（mCRC）中的实际结果
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2025-07-01 DOI: 10.1016/j.annonc.2025.05.054
P. Mascaró Baselga , F. Salvà Ballabrera , E. Garcia-Galea , R. Comas , F.J. Ros Montana , I. Baraibar Argota , M. Rodriguez Castells , N. Saoudi Gonzalez , C. Salva de Torres , J. Hernando Cubero , A. Garcia Alvarez , A. Garcia Rodriguez , A. Alcaraz , C. Vaghi , A. Plaja Salarich , S. Soriano , R. Querol Ninerola , J. Capdevila , J. Tabernero , E. Elez Fernandez
{"title":"42P Real-world outcomes of anti-EGFR rechallenge in RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC)","authors":"P. Mascaró Baselga , F. Salvà Ballabrera , E. Garcia-Galea , R. Comas , F.J. Ros Montana , I. Baraibar Argota , M. Rodriguez Castells , N. Saoudi Gonzalez , C. Salva de Torres , J. Hernando Cubero , A. Garcia Alvarez , A. Garcia Rodriguez , A. Alcaraz , C. Vaghi , A. Plaja Salarich , S. Soriano , R. Querol Ninerola , J. Capdevila , J. Tabernero , E. Elez Fernandez","doi":"10.1016/j.annonc.2025.05.054","DOIUrl":"10.1016/j.annonc.2025.05.054","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":"36 ","pages":"Page S26"},"PeriodicalIF":56.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
43P A canadian real-world evidence study of panitumumab with encorafenib in BRAF V600E mutated metastatic colorectal cancer (mCRC) 帕尼单抗联合恩科非尼治疗BRAF V600E突变的转移性结直肠癌（mCRC）的加拿大现实证据研究
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2025-07-01 DOI: 10.1016/j.annonc.2025.05.055
W.Y. Cheung , R.J. Wani , Y. Liu , T.N. Jarada , E. Ngan
{"title":"43P A canadian real-world evidence study of panitumumab with encorafenib in BRAF V600E mutated metastatic colorectal cancer (mCRC)","authors":"W.Y. Cheung , R.J. Wani , Y. Liu , T.N. Jarada , E. Ngan","doi":"10.1016/j.annonc.2025.05.055","DOIUrl":"10.1016/j.annonc.2025.05.055","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":"36 ","pages":"Page S27"},"PeriodicalIF":56.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
31P Derived neutrophil-to-lymphocyte ratio (dNLR) as a prognostic marker in metastatic colorectal cancer (mCRC): RAXO substudy 31P衍生中性粒细胞与淋巴细胞比率（dNLR）作为转移性结直肠癌（mCRC）预后标志物：RAXO亚研究
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2025-07-01 DOI: 10.1016/j.annonc.2025.05.043
M. Meklin , E. Osterlund , H.P. Stedt , S. Aho , A. Uutela , K.I. Lehtomaki , P. Halonen , L-M. Soveri , T. Salminen , A. Algars , R. Ristamaki , E. Heerva , R. Kallio , A. Lamminmäki , T.T. Muhonen , A. Nordin , H. Isoniemi , P.J. Osterlund
{"title":"31P Derived neutrophil-to-lymphocyte ratio (dNLR) as a prognostic marker in metastatic colorectal cancer (mCRC): RAXO substudy","authors":"M. Meklin , E. Osterlund , H.P. Stedt , S. Aho , A. Uutela , K.I. Lehtomaki , P. Halonen , L-M. Soveri , T. Salminen , A. Algars , R. Ristamaki , E. Heerva , R. Kallio , A. Lamminmäki , T.T. Muhonen , A. Nordin , H. Isoniemi , P.J. Osterlund","doi":"10.1016/j.annonc.2025.05.043","DOIUrl":"10.1016/j.annonc.2025.05.043","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":"36 ","pages":"Pages S18-S19"},"PeriodicalIF":56.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
64P PROMETCO: Real-world characteristics and safety outcomes of patients with metastatic colorectal cancer (mCRC) after two disease progressions, including patients with ECOG-PS >2 64P PROMETCO：两种疾病进展后的转移性结直肠癌（mCRC）患者的真实世界特征和安全结局，包括ECOG-PS bbb2患者
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2025-07-01 DOI: 10.1016/j.annonc.2025.05.076
R. Garcia-Carbonero , J-B. Bachet , C. Pinto , G.M. Bodoky , F.E. Marti , A. Mitroshkin , T. Buchler , P. Stübs , A.M. López Muñoz , R. Raman , E. Choucair , B. Chevallier , J. Alazzi , A. Sullivan , M. Koopman
{"title":"64P PROMETCO: Real-world characteristics and safety outcomes of patients with metastatic colorectal cancer (mCRC) after two disease progressions, including patients with ECOG-PS >2","authors":"R. Garcia-Carbonero , J-B. Bachet , C. Pinto , G.M. Bodoky , F.E. Marti , A. Mitroshkin , T. Buchler , P. Stübs , A.M. López Muñoz , R. Raman , E. Choucair , B. Chevallier , J. Alazzi , A. Sullivan , M. Koopman","doi":"10.1016/j.annonc.2025.05.076","DOIUrl":"10.1016/j.annonc.2025.05.076","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":"36 ","pages":"Page S35"},"PeriodicalIF":56.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
95P Adding quantitation to a tumor-informed molecular residual disease (MRD) assay to measure circulating tumor DNA as a marker of recurrence risk in patients with stage III colorectal cancer (CRC) 95P在肿瘤信息分子残留病（MRD）检测中增加定量，以测量循环肿瘤DNA作为III期结直肠癌（CRC）患者复发风险的标志物
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2025-07-01 DOI: 10.1016/j.annonc.2025.05.107
R.E. Schoen , B. Diergaarde , G. Young , D. Hall , T. Marti , A. Mazloom , G. Costa , S. Subramaniam , M.R. Palomares , J. Garces , R.F.L. Baehner
{"title":"95P Adding quantitation to a tumor-informed molecular residual disease (MRD) assay to measure circulating tumor DNA as a marker of recurrence risk in patients with stage III colorectal cancer (CRC)","authors":"R.E. Schoen , B. Diergaarde , G. Young , D. Hall , T. Marti , A. Mazloom , G. Costa , S. Subramaniam , M.R. Palomares , J. Garces , R.F.L. Baehner","doi":"10.1016/j.annonc.2025.05.107","DOIUrl":"10.1016/j.annonc.2025.05.107","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":"36 ","pages":"Pages S46-S47"},"PeriodicalIF":56.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
48P Impact of the KRAS mutation subtype on treatment response in metastatic colorectal cancer KRAS突变亚型对转移性结直肠癌治疗反应的影响
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2025-07-01 DOI: 10.1016/j.annonc.2025.05.060
N. Masri , M-L. Tanguy , E.J. El Rawadi , V. Boige , A.B. Mihele , E.M. Moujaes , M. Valery , A. Tarabay , C. Smolenschi , A.C. Fuerea , T. Pudlarz , M. Delaye , G.M. Camilleri , A. Hollebecque , M.P. Ducreux , A. Boileve
{"title":"48P Impact of the KRAS mutation subtype on treatment response in metastatic colorectal cancer","authors":"N. Masri , M-L. Tanguy , E.J. El Rawadi , V. Boige , A.B. Mihele , E.M. Moujaes , M. Valery , A. Tarabay , C. Smolenschi , A.C. Fuerea , T. Pudlarz , M. Delaye , G.M. Camilleri , A. Hollebecque , M.P. Ducreux , A. Boileve","doi":"10.1016/j.annonc.2025.05.060","DOIUrl":"10.1016/j.annonc.2025.05.060","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":"36 ","pages":"Pages S28-S29"},"PeriodicalIF":56.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144630568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
41P Switch from cetuximab (CET) to panitumumab (PANI) during encorafenib (ENCO)-based therapy in BRAF V600E mutated metastatic colorectal cancer (mCRC): An international multicenter analysis from the AGEO group 在BRAF V600E突变的转移性结直肠癌（mCRC）中，以恩科非尼（ENCO）为基础的治疗期间，从西妥昔单抗（CET）切换到帕尼单抗（PANI）：来自AGEO组的国际多中心分析
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2025-07-01 DOI: 10.1016/j.annonc.2025.05.053
A. Gandini , M.B. Landi , M.C. De Grandis , V. Probst , P. Girot , A. Pastorino , M. Decraecker , J.C. Jones , L. Grados , L. Sayah , I. Trouilloud , D. Tougeron , J. Taieb
{"title":"41P Switch from cetuximab (CET) to panitumumab (PANI) during encorafenib (ENCO)-based therapy in BRAF V600E mutated metastatic colorectal cancer (mCRC): An international multicenter analysis from the AGEO group","authors":"A. Gandini , M.B. Landi , M.C. De Grandis , V. Probst , P. Girot , A. Pastorino , M. Decraecker , J.C. Jones , L. Grados , L. Sayah , I. Trouilloud , D. Tougeron , J. Taieb","doi":"10.1016/j.annonc.2025.05.053","DOIUrl":"10.1016/j.annonc.2025.05.053","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":"36 ","pages":"Pages S25-S26"},"PeriodicalIF":56.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5O A double-blind placebo-controlled randomized phase II clinical trial to assess the efficacy of a topical BRAF inhibitor for acneiform rash toxicities from anti-EGFR therapies 一项双盲安慰剂对照随机II期临床试验，旨在评估局部BRAF抑制剂对抗egfr治疗引起的痤疮样皮疹毒性的疗效
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2025-07-01 DOI: 10.1016/j.annonc.2025.05.017
O. Purim , A. Patel , Z.A. Wainberg , E. Dotan , N. Shelach , E. Tahover , B. Corn , A. Ribas , M. Lacouture
{"title":"5O A double-blind placebo-controlled randomized phase II clinical trial to assess the efficacy of a topical BRAF inhibitor for acneiform rash toxicities from anti-EGFR therapies","authors":"O. Purim , A. Patel , Z.A. Wainberg , E. Dotan , N. Shelach , E. Tahover , B. Corn , A. Ribas , M. Lacouture","doi":"10.1016/j.annonc.2025.05.017","DOIUrl":"10.1016/j.annonc.2025.05.017","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":"36 ","pages":"Pages S4-S5"},"PeriodicalIF":56.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
68P Patients’ treatment experiences and involvement in treatment decision-making in metastatic colorectal cancer: Results of a patient survey in Europe and Canada 转移性结直肠癌患者的治疗经历和参与治疗决策：欧洲和加拿大的一项患者调查结果
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2025-07-01 DOI: 10.1016/j.annonc.2025.05.080
M.P. Saunders , F. Servidio , B.D. Stein , A. Mulvey , K. Steinberg , A. Geiger , S. Campbell , S. Gill
{"title":"68P Patients’ treatment experiences and involvement in treatment decision-making in metastatic colorectal cancer: Results of a patient survey in Europe and Canada","authors":"M.P. Saunders , F. Servidio , B.D. Stein , A. Mulvey , K. Steinberg , A. Geiger , S. Campbell , S. Gill","doi":"10.1016/j.annonc.2025.05.080","DOIUrl":"10.1016/j.annonc.2025.05.080","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":"36 ","pages":"Page S37"},"PeriodicalIF":56.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
59P Development and validation of a simple scoring system to identify patients with poor outcomes from resection of colorectal liver metastases (CRLM) despite technical resectability 开发和验证一种简单的评分系统，以识别技术上可切除的结直肠肝转移（CRLM）切除术后预后不良的患者
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2025-07-01 DOI: 10.1016/j.annonc.2025.05.071
H.J. Chong , L. Gardner , M.A. Noor , M.R. Mahmud , A.M. Alwetaidy , M.M. Ahmed , E. Postaleniec , N.A. Rahim , N. Bhardwaj , D. Malde , S. Rathinam , A. Kelkar , R. Agarwal
{"title":"59P Development and validation of a simple scoring system to identify patients with poor outcomes from resection of colorectal liver metastases (CRLM) despite technical resectability","authors":"H.J. Chong , L. Gardner , M.A. Noor , M.R. Mahmud , A.M. Alwetaidy , M.M. Ahmed , E. Postaleniec , N.A. Rahim , N. Bhardwaj , D. Malde , S. Rathinam , A. Kelkar , R. Agarwal","doi":"10.1016/j.annonc.2025.05.071","DOIUrl":"10.1016/j.annonc.2025.05.071","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":"36 ","pages":"Page S32"},"PeriodicalIF":56.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信